Find out how to get involved in the trial, and which hospitals are getting involved
Who can take part in the trial?
To be eligible to take part in the trial participants must:
- have one of the healthcare conditions of interest i.e. breast cancer, lung cancer, acute myeloid leukaemia, multiple myeloma, rheumatic/inflammatory conditions, chronic renal conditions, chronic liver conditions, inflammatory bowel disease, or have received treatment with haematopoietic stem cell transplant (HSCT) or chimeric antigen receptor (CAR) T cells.
- be eligible for vaccination and have not received the second dose of the vaccine (Group 1) or
- have not passed 28 days after second dose of the vaccine (Group 2)
- have an anticipated life expectancy of 6 months or more
Which hospitals are taking part in the trial?
- Addenbrooke’s Hospital, Cambridge
- Glasgow Royal Infirmary, Glasgow
- Hammersmith Hospital, London
- John Radcliffe Hospital, Oxford
- King’s College Hospital, London
- Queen Elizabeth Hospital, Birmingham
- Royal Hallamshire Hospital, Sheffield
- Southampton General Hospital, Southampton
- St James’s University Hospital, Leeds
Participant Identification Centres (PIC)
- Milton Keynes University Hospital NHS Foundation Trust
- Royal Berkshire NHS Foundation Trust